All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2026-N-4162
Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) manufactured by Moderna TX Inc.
Documents
1
Comments
0
Description
OPEN
Key Dates
Comment Period OpensMay 22, 2026
Comment Period ClosesJun 18, 2026
Documents
Keywords
CBER
2026-225
Notice
Vaccines and Related Biological Products
Advisory Committee
Request for Comments
Safety and Effectiveness of MFLUSIVA
(Influenza Vaccine, mRNA)
manufactured by Moderna TX Inc.
Data from Regulations.gov